Series E - Intarcia Therapeutics
Investment Firm
Overview
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Announced Date
Dec 29, 2016
Funding Type
Series E
Highlights
Location
United States, North America
Social
Participant Investors
2
| Investor Name |
|---|
 GWC Innovator Fund |
Round Details and Background
Intarcia Therapeutics raised $206000000 on 2016-12-29 in Series E
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Company Funding History
23
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Aug 30, 2012 |  Debt Financing - Intarcia Therapeutics | - | 45.8M | |
| Nov 16, 2012 | Venture Round - Intarcia Therapeutics | 7 | - | 160.0M |
| Sep 08, 2010 | Debt Financing - Intarcia Therapeutics | 3 | - | 5.0M |
| Mar 20, 2007 | Venture Round - Intarcia Therapeutics | 7 | - | 50.0M |
Recent Activity
There is no recent news or activity for this profile.